サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1722443

分子診断市場レポート：製品、技術、用途、エンドユーザー、地域別、2025年～2033年

Molecular Diagnostics Market Report by Product, Technology (Polymerase Chain Reactions, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology, and Others), Application, End Users, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 139 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
分子診断市場レポート：製品、技術、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2025年05月01日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の分子診断の市場規模は2024年に209億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに354億米ドルに達し、2025年から2033年にかけて5.75%の成長率（CAGR）を示すと予測しています。感染症や遺伝性疾患の有病率の増加、ポリメラーゼ連鎖反応（PCR）の技術進歩、高齢化人口の増加、疾患の早期発見に対する意識の高まり、政府の支援策が市場の軌道を形成する要因となっています。

分子診断市場分析：

主な市場促進要因：分子診断市場は、主に慢性疾患や感染症の増加により拡大しており、その結果、正確な診断方法に対する需要が高まっています。また、ゲノム医療や個別化医療の継続的な進歩が分子診断市場の成長に寄与しています。

主要市場動向：重要な動向には、正確で迅速なPCRの需要、新しい方法論や診断技術による試薬やキットの増加が含まれます。また、非侵襲的な早期診断アプローチへの動きも需要を支えています。

地理的動向：北米は、高度な医療インフラの存在、研究開発への投資の増加、個別化医療の重視により、世界をリードしています。また、アジア太平洋地域は、資源利用の増加、健康に関する知識と支出の増加により、急速な開発に直面しています。

競合情勢：常に市場に貢献している主要競合企業は、Roche Diagnostics、Abbott Laboratories、QIAGEN、Bio-Rad Laboratories、Siemens Healthineers、Thermo Fisher Scientificなどです。これらの企業は、分子診断の市場シェアを維持し、新たな領域を占有するために、新技術やパートナーシップに多額の投資を行っています。

課題と機会：障壁は、規制の複雑さと分子診断の財務です。課題とともに、ヘルスケアプロバイダーにとっては、新興市場における医療ニーズの高まりや、より良い診断と市場拡大を約束する絶え間ない技術進歩から、新たな機会が生まれます。

分子診断市場動向：

慢性疾患と感染症の蔓延

市場は著しい成長率を示しているが、これは主に急性疾患と慢性疾患の症例が増加しているためです。がん、心臓病、感染症を含むこのような疾病発生の増加は、疾病の迅速かつ適切な診断における分子診断の重要な役割に焦点を当てています。この特性は、より良い患者の転帰を可能にし、また個々の患者に対応した治療計画を構成し、市場における分子診断の需要を増加させます。世界中で複雑化する健康状態に伴い、新型の分子診断装置に対する需要が高まっており、これが市場の成長を永続させています。保健省の報告によると、2016年、非伝染性疾患（NCDs）は全死亡の61％、障害事例の55％を占めています。

ゲノミクスと個別化医療における技術の進歩

この分野では、世界の分子診断市場動向にとって極めて重要なゲノミクスと個別化医療の開発が進んでいます。DNA配列決定、遺伝子発現、RNAなどの次世代DNA配列決定のための遺伝子プロファイリング技術革新は不可欠であり、診断方法を変え、特定の疾患マーカーや遺伝的素因の同定を可能にしています。個人の遺伝子プロファイルに基づいて治療を調整する個別化医療の利用は、複雑な遺伝子情報を正確に解読できる高度な診断技術の必要性を生み出しています。高度な技術と個別化治療の連携が進み、市場シェアが拡大しています。

個別化医療報告書によると、2015年、米国のバラク・オバマ大統領は精密医療イニシアチブ（PMI）を立ち上げました。このイニシアチブは、綿密な科学研究のために、数千から始まり潜在的には100万ゲノム配列まで拡大する、広範なゲノムデータへの安全なアクセスを研究者に提供するものです。

高齢化の進展と標的診断薬への需要

高齢人口における神経変性疾患や心血管疾患などの疾病の増加により、効率的な診断法に対する需要が高まっています。分子診断は、健康状態の早期発見という貴重な機能を提供し、その結果、便利で治療成績の向上した治療への明確な道筋を提供します。この人口統計の増加傾向は、ラボオンチップ（LOA）技術のような非侵襲的で正確なツールに対する需要を著しく高めており、この新しい健康要件に適応しようとする市場セグメントの傾向が強まっていることを示しています。この人口シフトは、分子診断市場分析に大きく寄与しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の分子診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 試薬とキット
  • 機器
  • ソフトウェアとサービス

第7章 市場内訳：技術別

  • ポリメラーゼ連鎖反応（PCR）
  • 交配
  • DNAシーケンシング
  • マイクロアレイ
  • 等温核酸増幅技術（INAAT）
  • その他

第8章 市場内訳：用途別

  • 感染症診断
  • 腫瘍学
  • 遺伝子検査
  • 血液検査
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院
  • 研究所
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • Biomerieux SA
    • Danaher Corporation
    • Diasorin Molecular LLC（DiaSorin S.p.A.）
    • F. Hoffmann-La Roche AG（Roche Holding AG）
    • Hologic Inc.
    • Illumina Inc.
    • Myriad Genetics Inc.
    • Qiagen
    • Quidel Corporation
    • Thermo Fisher Scientific
図表

List of Figures

  • Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2024
  • Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
  • Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million USD), 2025-2033
  • Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Molecular Diagnostics Market: Key Players
目次
Product Code: SR112025A5726

The global molecular diagnostics market size reached USD 20.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 35.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.75% during 2025-2033. The increasing prevalence of infectious diseases and genetic disorders, technological advancements in polymerase chain reaction (PCR), growing aging population, surging awareness of early disease detection, and supportive government initiatives are factors shaping the market's trajectory.

Molecular Diagnostics Market Analysis:

Major Market Drivers: The market for molecular diagnostics is expanding primarily due to rise in chronic and infectious illnesses which in turn is leading to growing demand for accurate diagnostics methods. In addition, the continual advancements in genomic and personalized medicine are contributing to the molecular diagnostics market growth.

Key Market Trends: Substantial trends include the demand for PCR as it is accurate and fast and the increase in reagents and kits due to the new methodologies and diagnostic technologies. Besides, the movement towards non-invasive, early diagnosis approaches is also supporting the demand.

Geographical Trends: North America is the leader in the world, due to the presence of advanced medical infrastructure, more investments in R&D and a great emphasis on personalized medicine. In addition, Asia-Pacific faces a fast development through increasing resource usage and more health-related knowledge and spendings.

Competitive Landscape: The key competitive companies that are constantly contributing to the market are Roche Diagnostics, Abbott Laboratories, QIAGEN, Bio-Rad Laboratories, Siemens Healthineers, and Thermo Fisher Scientific and others. These enterprises invest heavily in the new technologies and partnerships to maintain the molecular diagnostics market share and occupy new territories.

Challenges and Opportunities: The barriers are regulatory intricacies and finances of the molecular diagnostics. Along with the challenges, new opportunities emerge for healthcare providers from the growing healthcare needs in the emerging markets and from the constant technological advances which promise better diagnostics and expand the market.

Molecular Diagnostics Market Trends:

Increasing prevalence of chronic and infectious diseases

The market is exhibiting an outstanding growth rate which is mainly due to the increasing cases of acute and chronic illnesses. This increase in disease occurrence, including cancer, heart diseases, and infection focuses on the significant role of the molecular diagnostics in giving fast and proper diagnosis of the disease. This attribute enables the better patient outcomes and also constitutes individual response personalized treatment plans, which increases the molecular diagnostics demand in the market. Along with the expanding complexities of health conditions all over the world, the demand for newfangled molecular diagnostic equipment is rising, which in turn perpetuates the market growth. According to a report by the ministry of health, in 2016, non-communicable diseases (NCDs) accounted for 61% of all mortalities and 55% of disability cases.

Technological advancements in genomics and personalized medicine

The sector is experiencing developments in genomics and personalized medicine that are crucial for the global molecular diagnostics market trends. Genetic profiling innovations for DNA sequencing, gene expression, and next-generation DNA sequencing such as RNA are essential and changing the ways of diagnosis and allowing the identification of specific disease markers and genetic predispositions. The utilization of personalized medicine, which entails to tailoring treatment based on the individual's genetic profile, is creating a need for sophisticated diagnostic technologies, that is able to decipher complex genetic information accurately. The rising cooperation between sophisticated technologies and tailored treatments is expanding the market share.

According to the personalized medicine report, in 2015, U.S. President Barack Obama launched the precision medicine initiative (PMI). This initiative offers researchers secure access to an extensive array of genomic data, starting with thousands and potentially expanding to one million genome sequences, for in-depth scientific research.

Rising aging population and demand for targeted diagnostics

The demand for efficient diagnostic method is rising due to rising illnesses, such as neurodegenerative disorders and cardiovascular problems in geriatric populations. Molecular diagnostics offer a valuable functionality of early detection of health conditions, thus providing a clear path for treatment at convenient and improved outcomes. The growing trend of this demographic is significantly increasing demand for non-invasive and accurate tools such as lab-on-a-chip (LOA) technology which is indicative of an increasing market segment's inclination to adapt to this new health requirement. This population shift is a significant contributing to the molecular diagnostics market analysis.

Molecular Diagnostics Market Segmentation:

Breakup by Product:

  • Reagents and Kits
  • Instruments
  • Software and Services

Reagents and kits dominate the market

The market is experiencing a significant increase, particularly in the reagents and kits segment, due to the expansion of molecular diagnostics reach into various medical areas of specialization. Fresh paradigms in research and novel inventions generate novel assays and testing methods that require the appropriate reagents and kits to be feasible. The growing number of chronic diseases make the need for fast and dependable diagnostic tools more crucial, driving the increase. Involvement of the major companies with research institutions also has an impact on the development of new reagents and kits, and hence plays a significant part in increasing the molecular diagnostics market revenue.

Breakup by Technology:

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Polymerase chain reactions (PCR) dominate the market

The PCR segment is dominating the molecular diagnostics market outlook. The advent of PCR technology refinements, including the designing and constructing of qPCR and dPCR, propel the amplification's biochemical process, thereby improves the sensitivity, accuracy, and speed. Such advancement of PCR has made it an indispensable instrument in molecular diagnostics. Precise analysis of genetic profiles which can be used in personalized medicine and targeted therapies is now essential to these treatments. Besides, the point-of-care diagnostics advancement and PCR platform introduction into both of the healthcare professionals and patients make molecular testing more available this leads broaden its integration among healthcare environments.

Breakup by Application:

  • Infectious Diseases Diagnostics
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

Infectious diseases diagnostics dominate the market

The molecular diagnostics market overview explains that the market dynamics are in line with rapid spread of infectious diseases, encompassing viral, bacterial, and fungal infections. The rapid spread of diseases, especially those which have the potential to plunge the world into pandemics, has caused an urgent need for early detection mechanism and the use of viable containment strategies. The advent of molecular biology and immunoassay technologies in diagnostics revolutionized this landscape by enhancing the accuracy and speed of pathogen detection and typing for their resistances. This breakthrough has led to the creation of a promising market for molecular diagnostics and indicates a strong trend of the growth of preventive health and surveillance projects. These measures play an important role in the medical involvement and stopping the spread of infections.

Breakup by End Users:

  • Hospitals
  • Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for molecular diagnostics.

North America market is growing due to the strong culture of perpetual research and development innovation, as per the molecular diagnostics market forecast period. With the increase in the development of chronic diseases, such as cancer, cardiovascular diseases and diabetes, the rapid and reliable detection methods are required. The increased level of personalized medicine understanding in healthcare professionals and patients alongside other factors is propelling the market growth. Development of government aid in the healthcare modernization and the establishment of molecular diagnostics techniques are the major economies drivers in the business growth. Furthermore, DTC genetic testing is also a significant part which improves the level of consumer interaction and supports the molecular diagnostics market recent opportunities.

Competitive Landscape:

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton Dickinson and Company
  • Biomerieux SA
  • Danaher Corporation
  • Diasorin Molecular LLC (DiaSorin)
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Hologic Inc.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • Qiagen
  • Quidel Corporation
  • Thermo Fisher Scientific

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Key molecular diagnostics companies are getting involved in the latest trends in the industry, such as Abbott Laboratories and Agilent Technologies Inc. Leading bio-pharmaceutical firms drive the improvements in diagnostic technology through introduction of newer, more precise, and better tested products. Besides, global giants are continuing to grow their presence across various regions with acquisitions, mergers, and different partnerships in order to increase their market share and facilitating the access to new markets. These strategic moves expand their product lines and improve the quality of their activity, catering to the all-time demand for a customized and point-of-care diagnoses. Molecular diagnostics recent developments include a merger of AI and machine learning technologies that better facilitate data analysis and enhance the accuracy of diagnostics.

Molecular Diagnostics Market News:

In May 2023, Becton Dickinson and Company announced to invest US$ 80 million in the construction of its third plant in Ciudad Juarez.

In January 2023, Agilent Technologies and Akoya Biosciences collaborated to develop multiplex-immunohistochemistry diagnostic products for tissue analysis. The companies also agreed to market end-to-end workflow solutions for multiplex assays in the clinical research market.

In April 2023, Abbott announced the acquisition of Cardiovascular Systems, Inc. (CSI), a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.

Key Questions Answered in This Report

  • 1.How big is the molecular diagnostics market?
  • 2.What is the future outlook of molecular diagnostics market?
  • 3.What are the key factors driving the molecular diagnostics market?
  • 4.Which region accounts for the largest molecular diagnostics market share?
  • 5.Which are the leading companies in the global molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reactions (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases Diagnostics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Genetic Testing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Screening
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerieux SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Hologic Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Qiagen
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quidel Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis